介绍欧洲胸外科及心脏外科常规抗凝治疗方法及用药。


EuropeanJournalofCardio-thoracicSurgery34(2008)73—92
doc.guandang.net
Guidelineonantiplateletandanticoagulationmanagementin
cardiacsurgery
JoelDunninga,MichelVersteeghb,AlessandroFabbric,AlainPavied,
PhilippeKolhe,UlfLockowandtf,SamerA.M.Nashefg,*onbehalfoftheEACTSAuditandGuidelinesCommittee
b
DepartmentofCardiothoracicSurgery,JamesCookUniversityHospital,Middlesbrough,UKDepartmentofCardiothoracicSurgery,LeidenUniversityMedicalCenter,Leiden,Netherlands
c
DepartmentofCardiacSurgery,VicenzoHospital,Italy
d
trie`reHospital,Paris,FranceInstituteofCardiology,LaPitie´-Salpe
e
DepartmentofCardiothoracicSurgery,UniversityHospitalofLiege,Liege,Belgiumf
DepartmentofCardiothoracicSurgery,KarolinskaUniversityHospital,Stockholm,Swedeng
DepartmentofCardiothoracicSurgery,PapworthHospitalCB233RE,Cambridge,UK
a
Received12December2007;receivedinrevisedform15February2008;accepted19February2008;Availableonline28March2008
Summary
Thisdocumentpresentsaprofessionalviewofevidence-basedrecommendationsaroundtheissuesofantiplateletandanticoagulationmanagementincardiacsurgery.ItwaspreparedbytheAuditandGuidelinesCommitteeoftheEuropeanAssociationforCardio-ThoracicSurgery(EACTS).Wereviewthefollowingtopics:evidenceforaspirin,clopidogrelandwarfarincessationpriortocardiacsurgery;perioperativeinterventionstoreducebleedingincludingtheuseofaprotininandtranexamicacid;theuseofthromboelastographytoguidebloodproductusage;protaminereversalofheparin;theuseoffactorVIIatocontrolseverebleeding;anticoagulationaftermechanical,tissuevalvereplacementandmitralvalverepair;theuseofantiplateletsandclopidogrelaftercardiacsurgerytoimprovegraftpatencyandreducethromboemboliccomplicationsandthromboprophylaxisinthepostoperativeperiod.Thisguidelineissubjecttocontinuousinformalreview,andwhennewevidencebecomesavailable.Theformalreviewdatewillbeat5yearsfrompublication(September2013).#2008EuropeanAssociationforCardio-ThoracicSurgery.PublishedbyElsevierB.V.Allrightsreserved.
Keywords:Evidence-basedmedicine;Guidelines;Thoracicsurgery;Antiplatelettherapy;Anticoagulationtherapy
1.Introduction
Antiplateletandanticoagulanttherapyisakeypartofthemanagementofpatientsundergoingcardiacsurgery.Mostheartoperationsdependoncardiopulmonarybypasswithsystemicheparinisation[1]and,postoperatively,everypatient’sthromboticandhaemorrhagictendencymustbecarefullymanaged.
Inrecentyears,thecostsandavailabilityofbloodandbloodproductshavechangeddramatically.Cardiothoracicsurgeryuses5%ofalldonatedbloodintheUKand10%ofbloodintheUSA.Thecostofdonorbloodandbloodproductshasincreasedandavailabilityisoftencriticallyreduced.Inadditiontothisshortage,thereisconcernoverblood-borneinfection,includingnewvariantCreutzfeld-Jacobdisease[2,3].Forthesereasonsitisparamountthatcardiacsurgeonsmakeeveryefforttominimisetheusageofbloodandbloodproductusageintheirpatients.
*Correspondingauthor.Tel.:+441480364299;fax:+441480364744.E-mailaddress:sam.nashef@papworth.nhs.uk(S.A.M.Nashef).
Thisguidelinewillpresentandsummarisetheevidenceforarangeoftherapeuticinterventionswiththeaimofhelpingcardiacsurgeonstooptimisetheusageofbloodandbloodproductsandtomoveawayfromcurrent,highlyvariablepractice[4,5]towardsauni ed,evidence-basedapproachtotheperioperativeuseofantiplateletandanticoagulanttherapy.
TheEuropeanAssociationforCardio-ThoracicSurgeryacknowledgestheguidelinedevelopmentworkperformedbyotherinstitutionsandinparticulartheworkoftheEuropeanSocietyforCardiology(ESC)guidelinesintheareaofmanagementofpatientsaftervalvesurgery[6,7]andtheSocietyofThoracicSurgeons(STS)guidelinesonperiopera-tivebloodtransfusionandbloodconservation[8].
2.Scopeoftheguideline
Thisguidelinecoversantiplateletandanticoagulationmanagementinrelationtocardiacsurgery,includingcardiopulmonarybypass,reversalofheparinisation,assess-
1010-7940/$—seefrontmatter#2008EuropeanAssociationforCardio-ThoracicSurgery.PublishedbyElsevierB.V.Allrightsreserved.doi:10.1016/j.ejcts.2008.02.024
欧洲心脏病学会(ESC)和欧洲心胸外科 协会(EACTS)制订的最新版心肌血运重建指南(...新型口服抗凝药首次在指南中获得推荐用于肺栓塞的治疗。 四、2014ESC 主动脉疾病...
引自2011年8月欧洲心脏病大会RE-LY房颤REGISTRY的结果发布 全球不同地区抗凝药物...2012 加拿大心房颤动指南 ? 2012 心房颤动导管和外科消融专家共识 ? 2012 心房...
2014心房颤动指南解读抗凝治疗_临床医学_医药卫生_...心脏外科手术、吸烟、体育锻炼、饮酒、甲状腺功能异常...欧洲血统、家族史以及基因异常、 ? 心电图提示左...
2010年欧洲心脏病学会心房颤动治疗指南概要_医药卫生...心房颤动抗凝治疗 与2006年房颤治疗指南相比,新指南...厨书期茄凝新指南推荐介入或外科术前应暂停维生素K...
因此,通过抗凝治疗预防卒中越来越成为广大医务工作者临床工作的重中之重。早在2010年欧洲心脏病学会(ESC)颁布的房颤治疗指南中,已将房颤的抗凝治疗摆在了房颤治疗的...
抗凝治疗关于静脉应用肝素及皮下应用低分子量肝素 的...卒中后头 24 小时内实施外科手术能够降低死亡率,可使... 2012年欧洲心脏病学会急... 3页 1下载券 2004...
(Acs) 糖尿病 老年人 妊娠 外科术后 AF 甲状腺...一般人群的患病率为 1%~2%超过 600 万欧洲 人...AF 的心脏复律一般要求有效的抗凝治疗,常常在手术前...
慢性心力衰竭诊断和治疗指南欧洲心脏学会 2012 急、...缺血性心力衰竭的外科治疗 TAPSE 三尖瓣环平面收缩... RAS 拮抗剂和抗凝治疗 (和监测治疗) (2) 检出...
慢性心力衰竭诊断和治疗指南欧洲心脏学会 2012 急、...缺血性心力衰竭的外科治疗 TAPSE 三尖瓣环平面收缩... RAS 拮抗剂和抗凝治疗 (和监测治疗) (2) 检出...
急性脑梗死的欧洲治疗指南.doc_临床医学_医药卫生_...2.3 抗凝治疗关于静脉应用肝素及皮下应用低分子量...(2)有下列情况时可应用 肝素:心房颤动及因心脏原因...
热门文档